Coexisting inherited or acquired factors for thrombosis
| Thrombosis risk factor | VE with or without PMn = 82 | PM only n = 19 |
|---|---|---|
| AT3, antithrombin III; FVL, factor V Leiden; MTHFR, methyltetrahydrofolate reductase; PC/S, protein C/protein S; PM, pregnancy morbidity; PT, prothrombin 20210A gene; VE, vascular events. | ||
| *Cholesterol: elevated low-density lipoprotein or low high-density lipoprotein | ||
| Oral contraceptive pills or hormone replacement therapy | 12 (15%) | 0 |
| Hypertension | 7 (9%) | 0 |
| Smoking | 13 (16%) | 1 (5%) |
| Surgery/immobilisation | 5 (6%) | 0 |
| Cholesterol* | 6 (7%) | 0 |
| Malignancy | 3(4%) | 0 |
| Postpartum | 3 (4%) | 0 |
| Other coagulopathy | ||
| FVL mutation | 1/21 (5%) | 0/3 |
| PT mutation | 3/19 (16%) | 0/2 |
| PC/S deficiency | 0/21 | 0/3 |
| AT3 deficiency | 1/19 (5%) | 0/3 |
| MTHFR mutation | 5/13(38%) | 2/4 (50%) |
| Renal failure | 1(1%) | 0 |